The Harmony prenatal test was developed by Ariosa Diagnostics, a CLIA-certified and CAP accredited clinical laboratory based in San Jose, CA. USA. In 2014, Ariosa joined Roche Diagnostics Corporation, the world’s largest biotech company and the leading provider of in-vitro diagnostics. The testing service is now supported by Roche’s global resources and 120+ years of dedication to advancing science to improve people’s lives.

The Harmony prenatal test was developed by Ariosa Diagnostics, a CLIA-certified laboratory. As with other laboratory-developed tests, it has not been cleared or approved by the FDA and is not available for sales as an IVD in the U.S. Non-invasive prenatal testing (NIPT) based on cell-free DNA analysis is not diagnostic; results should be confirmed by diagnostic testing.

ARIOSA, the Ariosa Logo, ARIOSA DIAGNOSTICS, the Ariosa Diagnostics Logo, HARMONY PRENATAL TEST and HARMONY are trademarks of Roche.

All other trademarks are the property of their respective owners.